With prostate cancer trial done, Peninsula drug maker will ask for FDA approval

Myovant Sciences also will seek FDA approval next year of a different version of the same drug to treat heavy menstrual bleeding in women with uterine fibroids.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 3, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news